Literature DB >> 14707061

NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.

Kerry S Campbell1, Sei-ichi Yusa, Akiko Kikuchi-Maki, Tracey L Catina.   

Abstract

NKp44 (NCR2) is a member of the natural cytotoxicity receptor (NCR) family that is expressed on activated human NK cells. We dissected structural attributes of NKp44 to determine their contributions to receptor function. Our results demonstrate that surface expression and NK cell activation by NKp44 is mediated through noncovalent association with the immunoreceptor tyrosine-based activation motif-containing protein, DAP12. Physical linkage to DAP12 requires lysine-183 in the NKp44 transmembrane domain. Intriguingly, the cytoplasmic domain of NKp44 also contains a sequence that matches the immunoreceptor tyrosine-based inhibitory motif (ITIM) consensus. By expressing a chimeric receptor in an NK-like cell line, we found that this ITIM-like motif from NKp44 lacks inhibitory capacity in a redirected cytotoxicity assay. The NKp44 cytoplasmic tyrosine was efficiently phosphorylated in the chimeric receptor upon treating the cells with pervanadate, but it was unable to recruit ITIM-binding negative effector phosphatases. We also generated NK-like cell lines expressing epitope-tagged wild-type or tyrosine to phenylalanine mutant (Y238F) versions of NKp44 and compared their capacities to induce activation marker expression, promote IFN-gamma production, or stimulate target cell cytotoxicity. We did not detect any tyrosine-dependent reduction or enhancement of NK cell activation through wild-type vs. Y238F mutant NKp44. Finally, the cytoplasmic tyrosine-based sequence did not provide a docking site for the AP-2 clathrin adaptor, nor did it potentiate receptor internalization. In summary, all activating properties and surface expression of NKp44 are mediated through its association with DAP12, and the putative ITIM in the NKp44 cytoplasmic domain does not appear to attenuate activating function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707061     DOI: 10.4049/jimmunol.172.2.899

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44.

Authors:  Joanna W Ho; Oren Hershkovitz; Malik Peiris; Alon Zilka; Ahuva Bar-Ilan; Beatrice Nal; Kid Chu; Mateusz Kudelko; Yiu Wing Kam; Hagit Achdout; Michal Mandelboim; Ralf Altmeyer; Ofer Mandelboim; Roberto Bruzzone; Angel Porgador
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

2.  Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.

Authors:  M von Lilienfeld-Toal; J Nattermann; G Feldmann; E Sievers; S Frank; J Strehl; I G H Schmidt-Wolf
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 3.  Dissecting human ILC heterogeneity: more than just three subsets.

Authors:  Yannick Simoni; Evan W Newell
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

4.  NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.

Authors:  Jianhua Yu; Takeki Mitsui; Min Wei; Hsiaoyin Mao; Jonathan P Butchar; Mithun Vinod Shah; Jianying Zhang; Anjali Mishra; Christopher Alvarez-Breckenridge; Xingluo Liu; Shujun Liu; Akihiko Yokohama; Rossana Trotta; Guido Marcucci; Don M Benson; Thomas P Loughran; Susheela Tridandapani; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

5.  Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Authors:  Kiran Kundu; Susmita Ghosh; Rhitajit Sarkar; Avishay Edri; Michael Brusilovsky; Orly Gershoni-Yahalom; Rami Yossef; Avishai Shemesh; Jean-Charles Soria; Vladimir Lazar; Ben-Zion Joshua; Kerry S Campbell; Moshe Elkabets; Angel Porgador
Journal:  Cancer Immunol Res       Date:  2019-06-04       Impact factor: 11.151

6.  NKp44 expression, phylogenesis and function in non-human primate NK cells.

Authors:  Andrea De Maria; Elisabetta Ugolotti; Erik Rutjens; Stefania Mazza; Luana Radic; Alessandro Faravelli; Gerrit Koopman; Eddi Di Marco; Paola Costa; Barbara Ensoli; Aurelio Cafaro; Maria Cristina Mingari; Lorenzo Moretta; Jonathan Heeney; Roberto Biassoni
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

7.  Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.

Authors:  Nathan C Horton; Stephen O Mathew; Porunelloor A Mathew
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

8.  The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.

Authors:  Irene Bonaccorsi; Claudia Cantoni; Paolo Carrega; Daniela Oliveri; Gabrielle Lui; Romana Conte; Michele Navarra; Riccardo Cavaliere; Elisabetta Traggiai; Marco Gattorno; Alberto Martini; Maria Cristina Mingari; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.

Authors:  Tal I Arnon; Jens T Kaiser; Anthony P West; Rich Olson; Ron Diskin; Birgit C Viertlboeck; Thomas W Göbel; Pamela J Bjorkman
Journal:  J Mol Biol       Date:  2008-07-03       Impact factor: 5.469

10.  NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.

Authors:  Oren Hershkovitz; Benyamin Rosental; Lior Ann Rosenberg; Martha Erika Navarro-Sanchez; Sergey Jivov; Alon Zilka; Orly Gershoni-Yahalom; Elodie Brient-Litzler; Hugues Bedouelle; Joanna W Ho; Kerry S Campbell; Bracha Rager-Zisman; Philippe Despres; Angel Porgador
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.